5484 Federal Register / Vol. 70, No. 21 / Wednesday, February 2, 2005 / Notices 

Electronics (Shenzhen) Ltd., Shenzhen, 

PEOPLE’S REPUBLIC OF CHINA; G3 

Mastering Solutions, Inc., Commerce, 

CA; Genesis Microchip Inc., Alviso, CA; 

Lightcomm Technology Co., Ltd., Hong 

Kong, HONG KONG–CHINA; Marvell 

International Ltd., Hamilton, 

BERMUDA; Meiloon Industrial Co., 

Ltd., Taoyuan City, TAIWAN; MultiConcept Industrial Ltd., Hong Kong, 

HONG KONG–CHINA; Nucom 

Technology Corporation, Taipei, 

TAIWAN; Paramount Digital 

Technology (Huizhou) Co., Ltd., 

Huizhou, PEOPLE’S REPUBLIC OF 

CHINA; Schotten Glassmastering—an 

der Heiden GmbH, Schotten, 

GERMANY; Soaring Technology Co., 

Ltd., Taipei-Hsien, TAIWAN; Storewell 

Medial Manufacturing Ltd., Taipei, 

TAIWAN; Sunext Technology 

Corporation Limited, Hsin-Chu, 

TAIWAN; and Zensonic Corporation Pty 

Ltd., Lonsdale, South Australia, 

AUSTRALIA have been added as parties 

to this venture. 

Also, Amusewell Technology Corp., 

Taipei, TAIWAN; Condor CD S.L., 

Calatayud, SPAIN; L&M Optical Disc 

West, LLC, Valencia, CPA; Media 

Solutions, Paris, FRANCE; Shenzhen 

Paragon Industries (China), Shenzhen 

Guangdong, PEOPLE’S REPUBLIC OF 

CHINA; Shenzhen Contel Electronics 

Technology, Shenzhen, PEOPLE’S 

REPUBLIC OF CHINA; Techsan I&C Co., 

Ltd., Gyeonggi-Do, REPUBLIC OF 

KOREA; and Yuxing Electronics 

Company Limited, Beijing, PEOPLE’S 

REPUBLIC OF CHINA have withdrawn 

as parties to this venture. Also, Time 

Group Ltd. has changed its name to 

Granville Technology Group Limited, 

Burnley, Lancashire, UNITED 

KINGDOM. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and DVD CCA 

intends to file additional written 

notification disclosing all changes in 

membership. 

On April 11, 2001, DVD CCA filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to section 6(b) of the 

Act on August 3, 2001 (66 FR 40727). 

The last notification was filed with 

the Department on October 1, 2004. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on November 29, 2004 (69 FR 

69393).

Dorothy B. Fountain, 

Deputy Director of Operations, Antitrust 

Division.

[FR Doc. 05–1987 Filed 2–1–05; 8:45 am] 

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Foundation for the 

Accreditation of Cellular Therapy 

Notice is hereby given that, on 

September 15, 2004, pursuant to section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

Foundation for the Accreditation of 

Cellular Therapy (‘‘FACT’’) has filed 

written notification simultaneously with 

the Attorney General and the Federal 

Trade Commission disclosing (1) the 

name and principal place of business of 

the standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to section 6(b) of the Act, the 

name and principal place of business of 

the standards development organization 

is: Foundation for the Accreditation of 

Cellular Therapy, Omaha, NE. The 

nature and scope of FACT’s standards 

development activities are: development 

of certain standards for medical 

facilities engaged in blood, bone marrow 

and cord blood transplantation in then 

treatment of human disease. FACT’s 

standards apply to all sources of 

hematopoietic progenitor cells and all 

phases of collection, processing, and 

administration of these cells. The 

standards encompass, but are not 

limited to, cells isolated from bone 

marrow or peripheral blood and any 

variety of manipulations including 

removal or enrichment of various cell 

populations, expansion of 

hematopoietic cell populations, 

cryopreservation, and infusion. The 

Standards fall into the following 

categories: (1) Clinical Program 

Standards; (2) Hematopoietic Progenitor 

Cell Collection Standards; (3) Donor and 

Cell Collection Standards; and (4) 

Hematopoietic Progenitor Cell 

Processing Standards. FACT’s standards 

have been made available to health 

institutions, health professionals, 

clinical laboratories, health facilities, 

and other interested members of the 

scientific and medical community and 

public. FACT’s voluntary standards are 

designed to provide minimum quality 

and safety guidelines for facilities and 

professionals performing hematopoietic 

progenitor cell therapy or providing 

related services. FACT has established a 

voluntary accreditation program for 

medical facilities that seek FACT 

certification of compliance with these 

standards. The goal of FACT’s 

accreditation program is to ensure that 

both the laboratory and clinical aspects 

of hematopoietic cell transplantion are 

conducted in accordance with the Fact 

standards. 

FACT has also developed cord blood 

bank standards. These standards were 

developed by consensus with 

representatives of NETCORD, individual 

members of ISCT, and other 

professionals active in cord blood 

banking. The cord blood bank standards 

fall into the following categories: (1) 

Cord Blood Bank Standards; (2) Cord 

Blood Donor and Collection Standards; 

(3) Cord Blood Processing Standards; 

and (4) Selection, Release and Shipping 

of Cord Blood Units. Such standards are 

designed to provide minimum 

guidelines for facilities and individuals 

performing cord blood collection, 

processing, testing, banking, selection 

and release or providing support 

services for such procedures.

Dorothy B. Fountain, 

Deputy Director of Operations, Antitrust 

Division.

[FR Doc. 05–1965 Filed 2–1–05; 8:45 am] 

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Hardwood Plywood & 

Veneer Association 

Notice is hereby given that, on 

September 20, 2004, pursuant to section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

Hardwood Plywood & Veneer 

Association (‘‘HPVA’’) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing (1) the name and 

principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting